WHO Certifies India’s Triumph Over Trachoma Elimination

The World Health Organization (WHO) has officially validated India’s elimination of trachoma as a public health problem, marking a significant achievement in public health. Trachoma, caused by the bacterium Chlamydia trachomatis, is one of the leading causes of global blindness. WHO Director-General Dr. Tedros Adhanom Ghebreyesus praised India for its commitment to combating this debilitating disease, joining the ranks of Nepal and Myanmar in the WHO South-East Asia Region and 19 other countries worldwide that have achieved this milestone.

Historical Context and Initiatives

India’s fight against trachoma dates back to 1963 when the Ministry of Health and Family Welfare launched a control project with support from WHO and UNICEF. The approach included surgical treatments, antibiotics, and water, sanitation, and hygiene (WASH) initiatives. Over the years, these efforts were integrated into the National Program for Control of Blindness and Visual Impairment (NPCBVI), allowing for expanded reach and effectiveness.

Recent Achievements and Strategies

In 2024, comprehensive surveys confirmed that elimination targets had been met in all previously endemic areas, following a significant reduction in trachoma prevalence—from 4% of blindness cases in 2005 to just 0.008% by 2018. The WHO validated these findings and recognized the effective implementation of the SAFE strategy: Surgery, Antibiotics, Facial cleanliness, and Environmental improvement.

Future Surveillance and Commitment

Moving forward, India has developed a post-validation surveillance plan to maintain the success achieved in eliminating trachoma, focusing on ongoing community awareness, provision of surgical services, and continued promotion of hygiene practices. This achievement stands as a beacon of hope for other nations striving to combat trachoma and improve public health, showcasing the impact of sustained commitment and effective health strategies over decades.